D. E. Shaw & Co »

Eliem Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $376k 29k 13.04
2021-09-30 $268k 15k 17.97

More positions owned by D. E. Shaw & Co

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices Put Option (AMD)
Amazon (AMZN)
Micron Technology Put Option (MU)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Bloom Energy Corp Com Cl A Put Option (BE)
Crowdstrike Hldgs Cl A Put Option (CRWD)
Sandisk Corp (SNDK)

View all positions for D. E. Shaw & Co

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics